{
    "nctId": "NCT03954197",
    "briefTitle": "Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients",
    "officialTitle": "Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients: a Randomized Controlled Study",
    "overallStatus": "UNKNOWN",
    "conditions": "Fertility Preservation, Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 204,
    "primaryOutcomeMeasure": "total number of mature oocytes cryopreserved",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* age between 18 and 38 years;\n* diagnosis of breast cancer (BC)\n* indication for neoadjuvant chemotherapy;\n* body mass index (BMI) \u226427kg/m2; regular ovulatory cycles;\n* transvaginal ultrasound showing the presence of two ovaries with an antral follicle count (AFC) between 10 and 30 follicles;\n* affiliation to the national social security system.\n* Written informed consent was obtained from all participants\n\nExclusion Criteria:\n\n* - previous chemotherapy, ovarian surgery or endometrioma;",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT"
}